AAAAAA

   
Results: 1-20 |
Results: 20
TOLERABILITY AND EFFICACY OF L-ACETYLCARNITINE IN PATIENTS WITH PERIPHERAL NEUROPATHIES - A SHORT-TERM, OPEN MULTICENTER STUDY
Authors: DEGRANDIS D
Citation: D. Degrandis, TOLERABILITY AND EFFICACY OF L-ACETYLCARNITINE IN PATIENTS WITH PERIPHERAL NEUROPATHIES - A SHORT-TERM, OPEN MULTICENTER STUDY, Clinical drug investigation, 15(2), 1998, pp. 73-79
ON THE ACTION OF BOTULINUM-NEUROTOXIN-A AND BOTULINUM-NEUROTOXIN-E ATCHOLINERGIC TERMINALS
Authors: WASHBOURNE P PELLIZZARI R ROSSETTO O BORTOLETTO N TUGNOLI V DEGRANDIS D ELEOPRA R MONTECUCCO C
Citation: P. Washbourne et al., ON THE ACTION OF BOTULINUM-NEUROTOXIN-A AND BOTULINUM-NEUROTOXIN-E ATCHOLINERGIC TERMINALS, J PHYSL-PAR, 92(2), 1998, pp. 135-139
NOVEL TRANSTHYRETIN MISSENSE MUTATION (THR34) IN AN ITALIAN FAMILY WITH HEREDITARY AMYLOIDOSIS
Authors: PATROSSO MC SALVI F DEGRANDIS D VEZZONI P JACOBSON DR FERLINI A
Citation: Mc. Patrosso et al., NOVEL TRANSTHYRETIN MISSENSE MUTATION (THR34) IN AN ITALIAN FAMILY WITH HEREDITARY AMYLOIDOSIS, American journal of medical genetics, 77(2), 1998, pp. 135-138
BOTULINUM TOXIN SEROTYPE-E AND SEROTYPE-A EFFECT IN HUMAN - AN ELECTROPHYSIOLOGICAL COMPARISON STUDY
Authors: DEGRANDIS D MONTECUCCO C ROSSETTO O TUGNOLI V ELEOPRA R
Citation: D. Degrandis et al., BOTULINUM TOXIN SEROTYPE-E AND SEROTYPE-A EFFECT IN HUMAN - AN ELECTROPHYSIOLOGICAL COMPARISON STUDY, Neurology, 50(4), 1998, pp. 5132-5132
BOTULINUM TOXIN SEROTYPE-C TREATMENT IN SUBJECTS AFFECTED BY FOCAL DYSTONIA AND RESISTANT TO BOTULINUM TOXIN SEROTYPE-A
Authors: ELEOPRA R TUGNOLI V DEGRANDIS D MONTECUCCO C
Citation: R. Eleopra et al., BOTULINUM TOXIN SEROTYPE-C TREATMENT IN SUBJECTS AFFECTED BY FOCAL DYSTONIA AND RESISTANT TO BOTULINUM TOXIN SEROTYPE-A, Neurology, 50(4), 1998, pp. 7008-7008
IDENTICAL DE-NOVO MUTATION AT THE D4F104S1 LOCUS IN MONOZYGOTIC MALE TWINS AFFECTED BY FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY (FSHD) WITH DIFFERENT CLINICAL EXPRESSION
Authors: TUPLER R BARBIERATO L MEMMI M SEWRY CA DEGRANDIS D MARASCHIO P TIEPOLO L FERLINI A
Citation: R. Tupler et al., IDENTICAL DE-NOVO MUTATION AT THE D4F104S1 LOCUS IN MONOZYGOTIC MALE TWINS AFFECTED BY FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY (FSHD) WITH DIFFERENT CLINICAL EXPRESSION, Journal of Medical Genetics, 35(9), 1998, pp. 778-783
THE VARIABILITY IN THE CLINICAL EFFECT INDUCED BY BOTULINUM TOXIN TYPE-A - THE ROLE OF MUSCLE-ACTIVITY IN HUMANS
Authors: ELEOPRA R TUGNOLI V DEGRANDIS D
Citation: R. Eleopra et al., THE VARIABILITY IN THE CLINICAL EFFECT INDUCED BY BOTULINUM TOXIN TYPE-A - THE ROLE OF MUSCLE-ACTIVITY IN HUMANS, Movement disorders, 12(1), 1997, pp. 89-94
GUIDELINES FOR THE THERAPEUTIC USE OF BOTULINUM TOXIN IN MOVEMENT-DISORDERS
Authors: BERARDELLI A ABBRUZZESE G BERTOLASI L CANTARELLA G CARELLA F CURRA A DEGRANDIS D DEFAZIO G GALARDI G GIRLANDA P LIVREA P MODUGNO N PRIORI A RUOPPOLO G VACCA L MANFREDI M
Citation: A. Berardelli et al., GUIDELINES FOR THE THERAPEUTIC USE OF BOTULINUM TOXIN IN MOVEMENT-DISORDERS, Italian journal of neurological sciences, 18(5), 1997, pp. 261-269
BOTULINUM TOXIN TREATMENT OF MUSCLE CRAMPS - A CLINICAL AND NEUROPHYSIOLOGICAL STUDY
Authors: BERTOLASI L PRIORI A TOMELLERI G BONGIOVANNI LG FINCATI E SIMONATI A DEGRANDIS D RIZZUTO N
Citation: L. Bertolasi et al., BOTULINUM TOXIN TREATMENT OF MUSCLE CRAMPS - A CLINICAL AND NEUROPHYSIOLOGICAL STUDY, Annals of neurology, 41(2), 1997, pp. 181-186
BOTULINUM NEUROTOXIN SEROTYPE-C - A NOVEL EFFECTIVE BOTULINUM TOXIN THERAPY IN HUMAN
Authors: ELEOPRA R TUGNOLI V ROSSETTO O MONTECUCCO C DEGRANDIS D
Citation: R. Eleopra et al., BOTULINUM NEUROTOXIN SEROTYPE-C - A NOVEL EFFECTIVE BOTULINUM TOXIN THERAPY IN HUMAN, Neuroscience letters, 224(2), 1997, pp. 91-94
LOWER-LIMB LENGTHENING IN SHORT STATURE - AN ELECTROPHYSIOLOGICAL ANDCLINICAL-ASSESSMENT OF PERIPHERAL-NERVE FUNCTION
Authors: POLO A ALDEGHERI R ZAMBITO A TRIVELLA G MANGANOTTI P DEGRANDIS D RIZZUTO N
Citation: A. Polo et al., LOWER-LIMB LENGTHENING IN SHORT STATURE - AN ELECTROPHYSIOLOGICAL ANDCLINICAL-ASSESSMENT OF PERIPHERAL-NERVE FUNCTION, Journal of bone and joint surgery. British volume, 79B(6), 1997, pp. 1014-1018
BOTULINUM NEUROTOXINS - MECHANISM OF ACTION AND THERAPEUTIC APPLICATIONS
Authors: MONTECUCCO C SCHIAVO G TUGNOLI V DEGRANDIS D
Citation: C. Montecucco et al., BOTULINUM NEUROTOXINS - MECHANISM OF ACTION AND THERAPEUTIC APPLICATIONS, Molecular medicine today, 2(10), 1996, pp. 418-424
BOTULINUM TOXIN TREATMENT IN THE FACIAL-MUSCLES OF HUMANS - EVIDENCE OF AN ACTION IN UNTREATED NEAR MUSCLES BY PERIPHERAL LOCAL DIFFUSION
Authors: ELEOPRA R TUGNOLI V CANIATTI L DEGRANDIS D
Citation: R. Eleopra et al., BOTULINUM TOXIN TREATMENT IN THE FACIAL-MUSCLES OF HUMANS - EVIDENCE OF AN ACTION IN UNTREATED NEAR MUSCLES BY PERIPHERAL LOCAL DIFFUSION, Neurology, 46(4), 1996, pp. 1158-1160
SURFACE MECHANOMYOGRAM REFLECTS MUSCLE-FIBERS TWITCHES SUMMATION
Authors: ORIZIO C LIBERATI D LOCATELLI C DEGRANDIS D VEICSTEINAS A
Citation: C. Orizio et al., SURFACE MECHANOMYOGRAM REFLECTS MUSCLE-FIBERS TWITCHES SUMMATION, Journal of biomechanics, 29(4), 1996, pp. 475-481
L-ACETYLCARNITINE IN THE TREATMENT OF PATIENTS WITH PERIPHERAL NEUROPATHIES - A SHORT-TERM, DOUBLE-BLIND CLINICAL-STUDY OF 426 PATIENTS
Authors: DEGRANDIS D SANTORO L DIBENEDETTO P
Citation: D. Degrandis et al., L-ACETYLCARNITINE IN THE TREATMENT OF PATIENTS WITH PERIPHERAL NEUROPATHIES - A SHORT-TERM, DOUBLE-BLIND CLINICAL-STUDY OF 426 PATIENTS, Clinical drug investigation, 10(6), 1995, pp. 317-322
SPINAL SOMATOSENSORY-EVOKED POTENTIALS IN PATIENTS WITH TETHERED CORDSYNDROME
Authors: POLO A ZANETTE G MANGANOTTI P BERTOLASI L DEGRANDIS D RIZZUTO N
Citation: A. Polo et al., SPINAL SOMATOSENSORY-EVOKED POTENTIALS IN PATIENTS WITH TETHERED CORDSYNDROME, Canadian journal of neurological sciences, 21(4), 1994, pp. 325-330
PATTERN OF MOTOR EVOKED-RESPONSE TO REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION
Authors: VALZANIA F QUATRALE R STRAFELLA AP BOMBARDI R SANTANGELO M TASSINARI CA DEGRANDIS D
Citation: F. Valzania et al., PATTERN OF MOTOR EVOKED-RESPONSE TO REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION, Electroencephalography and clinical neurophysiology, 93(4), 1994, pp. 312-317
BOTULINUM TOXIN TREATMENT IN PATIENTS WITH FOCAL DYSTONIA AND HEMIFACIAL SPASM - A MULTICENTER STUDY OF THE ITALIAN-MOVEMENT-DISORDER-GROUP
Authors: BERARDELLI A FORMICA A MERCURI B ABBRUZZESE G AGNOLI A AGOSTINO R CARACENI T CARELLA F DEFAZIO G DEGRANDIS D ELEOPRA R GIRLANDA P LEPORE V MESSINA C MILONE S PRIORI A STOCCHI F TUGNOLI V MANFREDI M
Citation: A. Berardelli et al., BOTULINUM TOXIN TREATMENT IN PATIENTS WITH FOCAL DYSTONIA AND HEMIFACIAL SPASM - A MULTICENTER STUDY OF THE ITALIAN-MOVEMENT-DISORDER-GROUP, Italian journal of neurological sciences, 14(5), 1993, pp. 361-367
THE INFLUENCE OF MUSCULAR LENGTHENING ON CRAMPS
Authors: BERTOLASI L DEGRANDIS D BONGIOVANNI LG ZANETTE GP GASPERINI M
Citation: L. Bertolasi et al., THE INFLUENCE OF MUSCULAR LENGTHENING ON CRAMPS, Annals of neurology, 33(2), 1993, pp. 176-180
RETINAL OSCILLATORY POTENTIAL ABNORMALITIES IN PATIENTS WITH CHRONIC-RENAL-FAILURE, BEFORE AND AFTER DIALYTIC TREATMENT
Authors: POLO A LAZZARINO L PITZORNO F BELTRAM E ZANETTE G DEGRANDIS D
Citation: A. Polo et al., RETINAL OSCILLATORY POTENTIAL ABNORMALITIES IN PATIENTS WITH CHRONIC-RENAL-FAILURE, BEFORE AND AFTER DIALYTIC TREATMENT, Documenta ophthalmologica, 82(3), 1992, pp. 257-265
Risultati: 1-20 |